Eclipse submits catheter-based TMR (transmyocardial revascularisation) for US approval
This article was originally published in Clinica
Executive Summary
In a move to extend the use of laser-based transmyocardial revascularisation (TMR) to interventional cardiologists, Eclipse Surgical Technologies has submitted its percutaneous TMR device for US approval.